Supporters

Technology and Heart Failure Therapeutics (THT) is sponsored by the Cardiovascular Research Foundation^® (CRF^®) and partially funded through educational grants from commercial supporters.  This program is made possible in part by the educational grant support of our industry colleagues who, like CRF^®, are dedicated to educating medical professionals and the public to enhance patient outcomes. CRF^® gratefully acknowledges the educational grant support from the following:
 

Major Benefactors

• Abbott
• CVRx, Inc.

Benefactors

• AstraZeneca
• Boston Scientific Corporation
• Corvia Medical
• Procyrion, Inc.
• Vectorious Medical Technologies
• WhiteSwell

Sponsors

• Abbott
• Ancora Heart
• Analog Devices
• AstraZeneca
• Bayer
• Boston Scientific
• BridgeBio
• Briohealth Solutions
• Cardiac Dimensions
• CVRx, Inc.
• Edwards
• Endotronix
• Heart Failure Society of America (HFSA)
• Impulse Dynamics
• Johnson & Johnson
• Johnson & Johnson MedTech (Abiomed)
• Novo Nordisk
• Nuwellis
• Pfizer
• Repreieve Cardiovascular
• scPharmaceuticals
• Sensible Medical